Lomustine (CCNU) in Dogs & Cats
Generic: Lomustine
Lomustine (CCNU) is a potent alkylating chemotherapy agent used primarily in veterinary oncology to manage various types of lymphoma, mast cell tumors, and certain brain tumors in dogs and cats.
This medication is intended for dogs and cats.
Overview
Lomustine, also known as CCNU, is a highly lipophilic nitrosourea compound utilized extensively in veterinary medicine for its ability to penetrate the blood-brain barrier. It acts as a powerful antineoplastic agent, frequently employed when other systemic treatments like Cyclophosphamide or Chlorambucil fail to achieve remission. Because it can cross into the central nervous system, it is considered a frontline defense against histiocytic sarcoma and high-grade central nervous system tumors. In many treatment protocols, it is combined with agents such as Prednisone to improve overall response rates and minimize resistance in lymphoid malignancies.
Beyond its neurological applications, Lomustine is a cornerstone in the treatment of cutaneous and systemic mast cell tumors. While tyrosine kinase inhibitors like Masitinib or Toceranib (Palladia) often target specific tumor mutations, Lomustine provides a broader alkylating effect that disrupts rapidly dividing cancer cells. Its efficacy is particularly notable in cases where surgical intervention is incomplete or the disease is aggressive, often proving more effective than heavy metal compounds like Cisplatin in specific feline and canine protocols.
Clinicians must exercise extreme caution during administration due to the drug's cumulative toxicity profile, particularly regarding the bone marrow and the liver. Unlike Vinblastine or Vinorelbine, which are administered intravenously, Lomustine is provided orally, requiring owners to handle the medication with specialized precautions to avoid exposure. Because it functions as an alkylating agent, periodic blood work is strictly required to monitor for neutropenia and thrombocytopenia, which are common dose-limiting factors that necessitate adjusting treatment schedules to prevent life-threatening secondary infections.
What It Treats
- Lymphoma: Used as a rescue therapy when primary CHOP protocols fail.
- Mast Cell Tumors: Used to manage high-grade or metastatic disease.
- Histiocytic Sarcoma: Highly effective due to its ability to cross the blood-brain barrier.
- Central Nervous System Tumors: Effective for brain-based malignancies due to high lipid solubility.
- Cutaneous Lymphoma: Addresses aggressive skin-based T-cell malignancies.
How It Works
Lomustine functions as an alkylating agent that chemically modifies DNA. By attaching alkyl groups to the guanine base of DNA, it induces cross-linking between DNA strands, which prevents the strands from unzipping for replication. This effectively halts the cell cycle and triggers apoptosis (programmed cell death) in rapidly dividing malignant cells. Because of its small molecular size and high lipid solubility, it can bypass the blood-brain barrier, a feature that distinguishes it from many other chemotherapy agents like [Mitoxantrone](/medications/mitoxantrone-in-dogs-and-cats) or [L-Asparaginase](/medications/l-asparaginase-in-dogs-and-cats). This unique property allows it to reach cancer cells hidden within the central nervous system that would otherwise be protected from traditional systemic treatment.
Dosage
Dosing is highly individualized based on the patient's body surface area (BSA) and specific health markers. It is typically administered every 3 to 6 weeks. It is imperative that owners follow the exact frequency provided by a veterinary oncologist, as accidental overdose can lead to severe marrow suppression.
Administration
Lomustine is an oral chemotherapy medication that must be handled with extreme care by the owner. It should be given whole; tablets should never be split, crushed, or chewed, as this can cause inhalation of hazardous particles. Owners should wear gloves when handling the medication and wash their hands thoroughly after administration. If a pet vomits or has diarrhea after a dose, feces and vomitus should be treated as biohazardous material for at least 48 hours.
Storage
Lomustine must be stored in a cool, dry place, typically at room temperature (around 59-77°F), away from moisture and light. It should be kept in its original, child-proof, and pet-proof container. Because it is a cytotoxic agent, it must be stored in a secure location completely inaccessible to children and other pets, and ideally away from food preparation areas.
Contraindications
Lomustine is contraindicated in patients with pre-existing bone marrow suppression or severe hepatic impairment, as the drug can exacerbate these conditions significantly. It should not be used in animals that are currently pregnant or lactating, as the drug is highly teratogenic and can cause fetal toxicity. Additionally, it should be used with extreme caution in patients who have recently undergone high-dose chemotherapy or radiation therapy, as the risk of catastrophic hematological depression is greatly elevated. Veterinarians must evaluate the patient’s liver function test results prior to each dose to ensure the liver can metabolize the drug safely.
Interactions
Known drug interactions primarily involve other myelosuppressive medications or hepatotoxic drugs. Combining Lomustine with other chemotherapeutic agents that also target the bone marrow, such as [Procarbazine](/medications/procarbazine-in-dogs-and-cats), requires careful dose reduction to avoid fatal blood counts. Furthermore, concurrent use of drugs that induce or inhibit hepatic cytochrome P450 enzymes can significantly alter the metabolism of Lomustine. Phenobarbital, for example, may change how the liver processes the medication, potentially increasing its toxicity. Always inform your oncologist of any supplements or concurrent medications the pet is receiving.
Side Effects
- Neutropenia (low white blood cell count)
- Thrombocytopenia (low platelet count)
- Hepatotoxicity (elevated liver enzymes or liver failure)
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- Anorexia (loss of appetite)
- Alopecia (hair loss, mostly in certain breeds)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
